Ultra-processed food consumption linked to distinct blood metabolic signature
Scientists have discovered 22 circulating metabolites that correlate with high intake of ultra-processed foods, providing biological evidence of metabolic distress.
A study published in the journal Critical Reviews in Food Science and Nutrition has identified a distinct biochemical fingerprint in human blood that correlates with the consumption of ultra-processed foods (UPFs). This research, led by Dr. Jessica Blanco-Lopez of the International Agency for Research on Cancer (IARC/WHO), provides granular biological evidence regarding how industrial food processing impacts human internal metabolic health.
The research team utilized targeted metabolomics to analyze blood samples and dietary data from 15,200 participants enrolled in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. By utilizing the Nova classification system — which categorizes foods into four groups ranging from unprocessed to ultra-processed — the researchers identified 22 circulating metabolites that appear to fluctuate in correlation with higher UPF intake.
Related imagery
Decoding the metabolic signature
The study found that individuals with high consumption of ultra-processed items exhibited specific chemical imbalances. Participants showed a pattern of high stearic acid levels paired with elevated long-chain polyunsaturated fatty acids. Researchers suggest this pattern implies that the metabolic impact of UPFs extends beyond the fat content of the products themselves, potentially stimulating the body to synthesize lipids internally from excess dietary carbohydrates.
The blood signatures also revealed the following markers of metabolic distress:
- Lipid profile alterations: Researchers observed an increase in lipid derivatives associated with impaired fatty acid oxidation and mitochondrial dysfunction.
- Depletion of beneficial lipids: There was a corresponding decrease in lipids essential for maintaining cell membrane stability, permeability, and signaling.
- Persistence of industrial fats: The presence of elaidic acid, an industrial trans fatty acid, indicated that even low levels of industrial fat exposure persist within the circulatory system.
Dr. Blanco-Lopez, who has a background in pediatrics and oncology, noted that the concurrent decline in protective fatty acids and the rise in markers of metabolic stress suggest that UPF consumption may contribute to health risks through both nutritional displacement, replacing whole foods with processed ones, and the active induction of metabolic disruption.
"Our study underscores the potential metabolic impact of UPFs and highlights the need for further research using targeted and untargeted metabolomics approaches to clarify the biological pathways linking food processing with chronic diseases and mortality."
Dr. Jessica Blanco-Lopez, IARC/WHO
Broader health implications
While the study establishes an association, it relies on a cross-sectional design, meaning it captures participants at a single point in time. As a result, the authors cautioned that the data cannot definitively prove that ultra-processed foods are the direct cause of these metabolic changes. The findings do not yet identify which specific food additives or product categories within the broad Nova "ultra-processed" group are the primary drivers of these signatures. Despite this, the evidence offers a biological explanation for long-observed statistical links between UPF consumption and chronic conditions, including cardiovascular disease, obesity, and type 2 diabetes.
The research adds a layer of objective biological data to existing dietary concerns. While traditional dietary guidelines already suggest limiting added sugars, saturated fats, and sodium, this study suggests that the overall formulation of refined carbohydrates, emulsifiers, and industrial fats may influence human biology in ways not fully captured by standard nutrient labels.
What to watch next
As the scientific community evaluates these findings, researchers have identified several paths for future study:
- Longitudinal validation: Implementing studies that follow participants over years to determine whether these metabolic signatures actually precede and predict the future onset of disease.
- Controlled feeding trials: Moving beyond observational questionnaires to strictly monitored clinical settings to confirm if specific UPFs induce these metabolic shifts directly.
- Diverse populations: Expanding the research to include non-European cohorts to see if these metabolic signatures remain consistent across different ethnic backgrounds and global dietary contexts.
- Biological integration: Combining metabolomics with gut microbiome and inflammatory marker research to build a holistic understanding of how industrial food processing interacts with internal bodily systems.
For now, experts involved in the field maintain that these findings are not ready for use as clinical diagnostic tools. Instead, they serve as a research foundation for understanding how modern dietary patterns may be driving chronic health issues at a molecular level.
Transparency record
Evidence behind this report
This report synthesizes 6 distinct sources. Open the source ledger below to compare the underlying coverage.
Prepared under the Archypedia Editorial Policy by the Lina Park editorial desk profile. AI-assisted tools may support drafting and verification; public accountability remains with Archypedia. Report an error.
